Propylthiouracil
Product Images NDC 0228-2348

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propylthiouracil (NDC 0228-2348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure of propylthiouracil, showing a heterocyclic ring with nitrogen, sulfur, oxygen, and a propyl side chain. Additional details include the molecular formula C7H10N2OS and molecular weight 170.23.*
FDA Label Image

Image 2

Image 2
Propylthiouracil tablet blister pack labeled with Actavis Pharma, Inc. The pack includes multiple round white tablets arranged in a grid. The label displays the proprietary name Propylthiouracil along with the NDC 0228-2348.*
FDA Label Image

Image 3

Image 3
Label for Propylthiouracil Tablets, USP 50 mg, manufactured by Teva Pharmaceuticals. The label indicates a package of 100 tablets, with instructions for pharmacists to dispense the accompanying Medication Guide. It includes dosage strength, storage instructions, a barcode, and NDC 0228-2348-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.